Affiliated​ Society Sessions

​​​Similarly to previous years, ESGO 2015 will have various sessions organised by its affiliated societies providing an essential opportunity for collaboration and connections to be formed across these societies. 


ASIAN SOCIETY OF GYNECOLOGIC ONCOLOGY (ASGO)

Update in the management of gynaecologic cancers

Coordinators: Soon Beom Kang (Korea) 
                      Toshiharu Kamura (Japan)

  • Laparoscopic radical hysterectomy in early cervical cancer
    Joo-Hyun Nam (Korea)
  • ​Surgery or CCRT for stage IIB cervical Cancer
    Miko Mikami (Japan)
  • Ovarian Cancer Screening
    Sarikapan Wilailak (Thailand)


EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC)

Immunotherapy and cervix cancer

Coordinators: Antonio Casado (Spain) 
                      Nelleke Ottevanger (The Netherlands)


  • ​Immunotherapy approaches in ovarian cancer
    ​Nelleke Ottevanger (The Netherlands)
  • Overview on HPV trials and an update on recent advances on HPV research
    Gemma Kenter (The Netherlands)
  • New lines of research in cervix cancer.  The new ROG-EORTC GCG working party and the EORTC 1414 trial
    Fernanda Herrera (Switzerlamd)
  • Complex vaccination strategies in cervical cancers
    Suzy Scholl (France)


THE EUROPEAN ORGANISATION FOR TREATMENT OF TROPHOBLASTIC DISEASES (EOTTD) 

Working Together: Improvement of Management of Gestational Trophoblastic Disease through National and International Collaboration

Coordinators: Leon Massuger (The Netherlands)
                      Nienke van Trommel (The Netherlands)

  • A trophoblastic disease center in France. 15 years of experience. A model for new centres in Europe?
    Jérôme​ Massardier (France)
  • Placental Site and Epithelioid Trophoblastic Tumour - a global perspective
    BW Hancock (United Kingdom)
  • Twin mole pregnancy - focus on clinical outcome and genetics
    Isa Niemann (Denmark)


EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO)

Multidisciplinary management of gynecological malignancies; a case-based interactive discussion

Coordinators: Nicoletta Colombo (Italy)
                      Jonathan Ledermann (United Kingdom)
  • Importance of multidisciplinary management of gynaecological cancers
    Jonathan Ledermann (United Kingdom)
  • Case 1: Multidisciplinary management of advanced ovarian cancer
    • Surgery or neoadjuvant chemotherapy
      Nicoletta Colombo (Italy)
    • Current choices for first line therapy
      Jonathan Ledermann (United Kingdom)
    • Managing early relapse- experimental therapeutics
      Cristiana Ses​sa (Switzerland)
    • Discussion
  • Case 2: Multidisciplinary management of Cervical Cancer
    • Surgical management of early disease
      Nicoletta Colombo (Italy)
    • Current options for relapsed cervical cancer
      Jonathan Ledermann (United Kingdom)
    • Horizon scanning-emerging strategies for recurrent disease
      Cristiana Sessa (Switzerland)
    • Discussion
  • Closure/summary
    Nicoletta Colombo (Italy)


EUROPEAN SOCIETY OF PATHOLOGY (ESP)

Clinician Meets Pathologist on Gynaecological Tumours

Coordinators: Maria-Rosaria Raspollini (Italy)​
                      Vesna Kesic (Serbia)​

  • ​Adenocarcinoma of the cervix: Key histopathological criteria which tailor an optimal treatment
    Ermina Iljazović​ (Bosnia and Herzegovina)
  • What is new in pathology and genetics of endometrial cancer
    Jaime Prat (Spain)
  • New Developments in Ovarian Epithelial Tumours
    Glenn McCluggage (United Kingdom)
  • Discussion


EUROPEAN SOCIETY FOR RADIOTHERAPY & ONCOLOGY (ESTRO)

Advanced cervical cancer: towards a more personalised radiation treatment

Coordinators: Christine HaieMeder (France)​
                      Richard Pötter (Austria)

  • Brachytherapy data: Which doses for which tumours?
    Jacob Lindegaard (Denmark)
  • Dose adaptation for pelvic / para-aortic nodes
    Ina Jϋrgenliemk-Schulz (The Netherlands)
  • Radiation Therapy and anti-HPV treatment
    Eric Deutsch (France)


INTERNATIONAL SOCIETY OF PSYCHO ONCOLOGY (IPOS)

Psycho-Oncological Support as a Joint Effort for Cancer Patients

Coordinators: Anja Mehnert (Germany)
                      Annette Hasenburg (Germany)

  • ​Cooperation of ESGO and IPOS
    Vesna Kesic (Serbia)
    Anja Mehnert (Germany)​
  • ​Psychological distress associated with breast and ovarian cancer risk genetic testing and medical management  
    Anne Bredart (France)
  • Cancer as a disease that involves all family members
    Snežana Mijalkovic​ (Serbia)
  • ​Mental disorders in patients with gynaecological cancers
    Anja Mehnert (Germany)
  • Survivorship: How can we support our patients​?
    Annette Hasenburg (Germany)


Keep Me Updated